i luv me some chemo (@drjameslynam) 's Twitter Profile
i luv me some chemo

@drjameslynam

Medical oncologist. Myriad interests, expert in ... opinions my own

ID: 1016264866032570369

calendar_today09-07-2018 10:16:40

46 Tweet

64 Followers

115 Following

Antonio Giordano, MD PhD (@antgiorda) 's Twitter Profile Photo

Characteristics of 6,801 #COVID19 patients dying in Italy🇮🇹: median age 78, men 70.4%. Pre-existing conditions available in 710 patients dying in-hospital: 17% active #cancer in the past 5 years. Time from hospitalization to death only 2 days longer if ICU (6d vs. 4d) Istituto Superiore di Sanità

Characteristics of 6,801 #COVID19 patients dying in Italy🇮🇹: median age 78, men 70.4%. Pre-existing conditions available in 710 patients dying in-hospital: 17% active #cancer in the past 5 years. Time from hospitalization to death only 2 days longer if ICU (6d vs. 4d) <a href="/istsupsan/">Istituto Superiore di Sanità</a>
Professor Henry Woo (@drhwoo) 's Twitter Profile Photo

This is probably the most balanced and fair assessment of the Charlie Teo enigma. “Like shooting Bambi': why Teo critics were gun-shy as media built the miracle-surgeon myth” smh.com.au/national/like-…

Cancer Institute NSW (@cancernsw) 's Twitter Profile Photo

The Cancer Clinical Research Network at HNE Health! Accepted by Dr James Lynam and Rosemary Carroll on behalf of the many people involved across the entire Network. Congratulations, team! #cancerNSWawards

Cancer Institute NSW (@cancernsw) 's Twitter Profile Photo

Congratulations to the Cancer Clinical Research Network and HNE Health – 2020 Outstanding Cancer Clinical Trials Unit. Find out more about their work to lead clinical trial recruitment and enrolment: cancer.nsw.gov.au/what-we-do/eve… #cancerNSWawards

Congratulations to the Cancer Clinical Research Network and <a href="/HNEHealth/">HNE Health</a> – 2020 Outstanding Cancer Clinical Trials Unit.

Find out more about their work to lead clinical trial recruitment and enrolment: cancer.nsw.gov.au/what-we-do/eve… #cancerNSWawards
Cancer Institute NSW (@cancernsw) 's Twitter Profile Photo

Find out how the Cancer Clinical Research Network is striving to break down geographical boundaries – giving more people in the Hunter New England region access to potentially life-changing clinical trials. cancer.nsw.gov.au/what-we-do/eve… #cancerNSWawards

i luv me some chemo (@drjameslynam) 's Twitter Profile Photo

A long year comes to an end. Looking through this list there are so many people can’t be replaced. Oddly enough the one that affected me the most was June Benicoff. I hope she’s happy being reunited with Leon! bbc.co.uk/news/entertain…

Surgical SHO CT BNO (2019) (@abdopainhotline) 's Twitter Profile Photo

Now, this is a story all about how My training got flipped-turned upside down And I liked to take a minute Just sit right there I'll tell you how I became redeployed in crit care.

Helen Czerski (@helenczerski) 's Twitter Profile Photo

A friend has just shown me this book "Calculus made easy", published in 1914, and I think it's got one of the best prologues I've ever seen. This is *exactly* what textbooks should be doing. And they should all be honest about how terrifying the topic names are too.

A friend has just shown me this book "Calculus made easy", published in 1914, and I think it's got one of the best prologues I've ever seen.  This is *exactly* what textbooks should be doing.  And they should all be honest about how terrifying the topic names are too.
i luv me some chemo (@drjameslynam) 's Twitter Profile Photo

Great work by Benoy Shah MD !! I shudder to think of a similar study in Oncology!! Analysis of conflicts of interest among authors and researchers of European clinical guidelines in cardiovascular medicine rcpjournals.org/content/clinme…

i luv me some chemo (@drjameslynam) 's Twitter Profile Photo

Merck’s KEYTRUDA® (pembrolizumab) Demonstrated Superior Disease-Free Survival (DFS) Compared With Placebo as Adjuvant Therapy in Patients With Renal Cell Carcinoma (RCC) Following Surgery | Business Wire businesswire.com/news/home/2021…

Toni Choueiri, MD (@drchoueiri) 's Twitter Profile Photo

8/ Pembrolizumab significantly improved DFS as compared to placebo (HR=0.68 ; 95%CI: 0.53-0.87 ; p=0.002, 2-sided), with benefits identified across most key subgroups (all HR<1). DFS rates at 2 years were 77.3 and 68.1% in the pembrolizumab and placebo groups, respectively.

8/ Pembrolizumab significantly improved DFS as compared to placebo (HR=0.68 ; 95%CI: 0.53-0.87 ; p=0.002, 2-sided), with benefits identified across most key subgroups (all HR&lt;1). DFS rates at 2 years were 77.3 and 68.1% in the pembrolizumab and placebo groups, respectively.
Craig Gedye (@drcraiggedye) 's Twitter Profile Photo

Medical Oncologist roles at #CalvaryMaterNewcastle. Join our busy academic service. Two Permanent Part-time Positions (0.5 FTE/20 hours per week) calvarycareers.mercury.com.au/ViewPosition.a… Please share.

Medical Oncologist roles at #CalvaryMaterNewcastle. Join our busy academic service. Two Permanent Part-time Positions (0.5 FTE/20 hours per week) calvarycareers.mercury.com.au/ViewPosition.a… Please share.
Craig Gedye (@drcraiggedye) 's Twitter Profile Photo

Join our #MedicalOncology team in Newcastle as a #ClinicalTrial Fellow. One of NSW busiest clinical research teams, gain wide experience and see many opportunities. Immediate start, FT or PT, and multi-year possible. calvarycareers.mercury.com.au/ViewPosition.a… Credit: Ian Nord

Join our #MedicalOncology team in Newcastle as a #ClinicalTrial Fellow. One of NSW busiest clinical research teams, gain wide experience and see many opportunities. Immediate start, FT or PT, and multi-year possible. calvarycareers.mercury.com.au/ViewPosition.a… Credit: Ian Nord
Medical Oncology Group of Australia (@moga_org) 's Twitter Profile Photo

Job Opportunity: Calvary Mater Newcastle seeks Medical Oncology Advanced Trainee. Fixed term full-time. Closes 21 July. moga.org.au/oncology-posit…

Job Opportunity:
Calvary Mater Newcastle seeks Medical Oncology Advanced Trainee.
Fixed term full-time.
Closes 21 July.
moga.org.au/oncology-posit…